[Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]

Area of Science:

• Nephrology
• Cardiology
• Hypertension Research

Context:

• Permanent hypertension often presents with early-stage increased glomerular permeability to albumin, signaling renal involvement and endothelial dysfunction.
• Microalbuminuria is defined as urinary albumin excretion of 30-300 mg/24 hours, confirmed over three months.
• Prevalence is 5-8% in the general population and 6-24% in hypertensive individuals.

Purpose:

• To define microalbuminuria and its measurement methods.
• To highlight its significance as a marker of cardiovascular and renal risk in hypertensive patients.
• To discuss clinical recommendations for its detection and measurement in various contexts.

Summary:

• Microalbuminuria, characterized by specific urinary albumin excretion levels, can be accurately measured using sensitive radio-immunological, immunonephelometric, and Elisa methods.
• High intra-individual variability necessitates consistent measurement techniques and repeat testing.
• Its presence in hypertensive patients signifies heightened cardiovascular and renal risk, guiding clinical management and research.

Impact:

• Microalbuminuria measurement serves as a vital clinical research tool for evaluating cardiovascular and renal risk in hypertension.
• Early detection and monitoring can inform therapeutic strategies and improve patient outcomes.
• Further studies on antihypertensive drug effects on microalbuminuria are recommended for better risk assessment.